For example, miR-15a, miR-15b, and miR-16 are able to inhibit the expression of CXCL1 and mediate the therapeutic effects of exosomes from hUC-MSCs in models of acute kidney injury [32]. This evidence concerns the gene CXCL1 and acute kidney injury.